AGIOS PHARMACEUTICALS, INC. — Director's Dealing 2017

Jan 4, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AGIOS PHARMACEUTICALS INC (AGIO)
CIK: 0001439222
Period of Report: 2016-12-30

Reporting Person: CLARK IAN T (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-12-30	Stock option (right to buy)	$41.73	A	16000	Acquired	2026-12-29	Common stock (16000)	Direct

Footnotes

F1: This option was granted on December 30, 2016. The shares underlying this option vest as to 25% of the underlying shares on December 30, 2017, with the remaining 75% vesting in 36 equal monthly installments thereafter.